Business
biOasis Appoints Christopher P. Lowe, M.B.A. as Chief Financial Officer and Board Advisor
biOasis Appoints Christopher P. Lowe, M.B.A. as Chief Financial Officer and Board Advisor.
About this update from Bioasis Technologies Inc.
[{"type":"text","content":"\n \n BIOASIS \n TECHNOLOGIES INC. (OTCQB:BIOAF; TSX.V:BTI), a biopharmaceutical \n company focused on overcoming the limitations of therapeutic drug \n delivery across the blood-brain barrier (BBB) and into the central \n nervous system for the treatment of neurological diseases and disorders, \n today announced the appointment of Christopher P. Lowe, M.B.A., as chief \n financial officer and board advisor. Lowe will report to Mark Day, \n Ph.D., president and chief executive officer of biOasis and will be \n responsible for the company’s corporate and financial strategy, \n including transactions and fundraising.\n \n\nThis press release features multimedia. View the full release here: \nhttp://www.businesswire.com/news/home/20171002005702/en/\n\n \n \n Bioasis appoints Christopher P. Lowe, M.B.A. as chief financial officer and advisor to the board of directors. Lowe brings extensive experience serving as an executive and board member for early, research-stage biotechnology companies. (Photo: Business Wire) \n\n\n \n “Chris is an impressively accomplished executive who brings significant \n corporate and financial experience to biOasis, including the strategic \n transactional, fundraising and M&A expertise needed to advance the \n company,” said Dr. Day. “We are fortunate to have him join us and I \n truly look forward to working with Chris during this transformational \n time for biOasis.”\n \n \n “I believe in the incredible potential of the biOasis proprietary \n blood-brain barrier technology platform. I am eager to work with Mark, \n the board of directors and the leadership team to develop a meaningful \n path forward for biOasis,” said Lowe.\n \n \n About Christopher P. Lowe, M.B.A.\n \n \n Christopher P. Lowe, M.B.A., has over 15 years of senior management \n experience as president, chief business officer and chief financial \n officer (CFO) of various private and public life sciences, medical \n technology and technology companies. Since January 2014, Mr. Lowe has \n been a partner at FLG Partners, a leading CFO services and board \n advisory firm in Silicon Valley, where he also sits on FLG’s Management \n Committee. Prior to joining FLG, Lowe served as a strategy, financial \n and management consultant to several public and private c...